These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy. Rosenoff SH. Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907 [Abstract] [Full Text] [Related]
29. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease. Bridge AT, Nelson RP, Schwartz JE, Mirowski GW, Billings SD. Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954 [Abstract] [Full Text] [Related]
36. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E. Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799 [Abstract] [Full Text] [Related]
37. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Transplantation; 2006 May 27; 81(10):1390-7. PubMed ID: 16732175 [Abstract] [Full Text] [Related]
38. [Symptomatic therapy of severe diarrhea in eosinophilic gastroenteritis with the somatostatin analog octreotide (Sandostatin)]. Rausch T, Gyr K, Wegmann W, Germer M, Meier R. Schweiz Med Wochenschr Suppl; 1997 May 27; 89():9S-13S. PubMed ID: 9289842 [Abstract] [Full Text] [Related]